Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Fanconi Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine phosphate 7Cyclophosphamide 6Antilymphocyte Serum 6Busulfan 5fludarabine 4Melphalan 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2SRA737 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2AP 1903 reagent 2sargramostim 1prexasertib 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Spectrometry, Fluorescence 1Reverse Transcriptase Polymerase Chain Reaction 1Quercetin 1Polymerase Chain Reaction 1Optical Imaging 1Molecular Diagnostic Techniques 1Microarray Analysis 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fanconi Anemia × SRA737 × Clear all
NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
153 enrolled
Classical hematologySarcomaThoracic

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡